inclusion criteria: * patients over 18 years of age * diagnosis of covid-19 pneumonia that would have required hospital admission * post covid-19 organized pneumonia diagnosis * without any contraindication to the study drug * that, adequately informed, voluntarily agree to participate in the study after knowing its objectives and risks and grant their written consent.

inclusion criteria: * patients over 18 years of age * diagnosis of covid-19 pneumonia that would have required hospital admission * post covid-19 organized pneumonia diagnosis * without any contraindication to the study drug * that, adequately informed, voluntarily agree to participate in the study after knowing its objectives and risks and grant their written consent.

inclusion criteria: - patients over 18 years of age - diagnosis of covid-19 pneumonia that would have required hospital admission - post covid-19 organized pneumonia diagnosis - without any contraindication to the study drug - that, adequately informed, voluntarily agree to participate in the study after knowing its objectives and risks and grant their written consent.

inclusion criteria: - patients over 18 years of age - diagnosis of covid-19 pneumonia that would have required hospital admission - post covid-19 organized pneumonia diagnosis - without any contraindication to the study drug - that, adequately informed, voluntarily agree to participate in the study after knowing its objectives and risks and grant their written consent.